United States · FDA National Drug Code directory
TOFACITINIB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-268_57e3cc57-9fe8-b19b-e063-6394a90aae90
- Product NDC
- 42571-268
- Form
- TABLET, FILM COATED
- Composition / generic term
- tofacitinib
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260603
- Source listing expiry
- 20271231
Source-listed ingredients
- TOFACITINIB CITRATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (42571-268-05) · 42571-268-05
- 30 TABLET, FILM COATED in 1 BOTTLE (42571-268-30) · 42571-268-30
- 60 TABLET, FILM COATED in 1 BOTTLE (42571-268-60) · 42571-268-60
- 150 BLISTER PACK in 1 CARTON (42571-268-76) / 15 TABLET, FILM COATED in 1 BLISTER PACK (42571-268-13) · 42571-268-76
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →